BlueOcean NutraSciences To Present at the NPC-NCN Toronto Investor Day June 21
June 13, 2017 (Source) – BlueOcean NutraSciences Inc. (TSXV:BOC) (“BlueOcean” or the “Company”) is pleased to announce that the Company was selected to present at the first annual Natural Products Canada (NPC) and Nutrition Capital Network’s (NCN) joint Conference for Investors in Toronto, Canada to be held June 21 at the downtown Marriott.
As a prerequisite for presenting, the Company was required to file an updated abbreviated Business Plan with NCN that is now available on the company’s website www.blueoceannutra.ca under Investors – Investor Materials.
This is part of ongoing Company efforts at conferences, trade shows and other forums to expand awareness of BlueOcean’s patent protected sustainable and natural shrimp oil products to both consumers and distributors and to existing and potential shareholders.
About Natural Products Canada (NPC)
Canada’s NPC is a nationwide not for profit Centre of Excellence for commercialization and research of natural products including dietary supplements and nutritional ingredients. Its network includes companies, investors, research institutes, and innovation and commercialization experts to Connect, Evaluate, Accelerate and Invest to help bring products to market faster, cheaper and more efficiently.
About Nutrition Capital Network (NCN)
Get our daily investorintel update
San Francisco based NCN connects investors with high-potential growth companies in the nutrition and health and wellness industry. NCN also provides cutting edge research based industry knowledge and serves as a gateway to connections, insights and resources. Since 2007, 545 companies have presented at 31 NCN investor meetings in the US and the EU.
BlueOceanNutraSciences Inc. is a Canadian public listed company (TSXV:BOC) whose mission is to develop effective, innovative and sustainable products from Natural Sources, to improve the lives of its customers. This includes naturally accelerating plant growth. BlueOcean’s first specialty ingredient is its patent protected shrimp oil which is the base for its current three consumer brands. Shrimp oil is made from sustainably certified North Atlantic coldwater shrimp shells (the by-product of the cooked and peeled shrimp process) and contains phospholipid bound omega- fatty acids and over 40 times more natural astaxanthin compared to krill oil ingredients.
Shrimp oil’s unique nutritional properties enables the ingredient to make numerous health claims across a wide range of markets, including the $4Bn omega-3 heart healthmarket, the $9Bn joint health market and the $10Bn sports supplement market. BlueOcean markets its shrimp oil ingredient through a number of consumer brands that are formulated to target these specific markets.
BlueOcean currently markets its shrimp oil under three consumer brands: Pure Polar(R) Omega-3 Shrimp Oil, Joint AXTM and Sport AXTM. Products may be purchased online at purepolarlabs.com.
This news release may contain forward-looking statements that are based on BlueOcean’s expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
InvestorIntel is a trusted source of reliable information at the forefront of emerging markets that brings investment opportunities to discerning investors.